The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Dale J. Kempf

Global Pharmaceutical Research & Development Division Abbott

Abbott Park



Name/email consistency: high



  • Global Pharmaceutical Research & Development Division Abbott, Abbott Park, USA. 2007
  • Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064, USA. 2001 - 2006


  1. Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavir. Kempf, D.J., Klein, C., Chen, H.J., Klein, L.L., Yeung, C., Randolph, J.T., Lau, Y.Y., Chovan, L.E., Guan, Z., Hernandez, L., Turner, T.M., Dandliker, P.J., Marsh, K.C. Antivir. Chem. Chemother. (2007) [Pubmed]
  2. Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitors. Kempf, D.J., Waring, J.F., Morfitt, D.C., Werner, P., Ebert, B., Mitten, M., Nguyen, B., Randolph, J.T., DeGoey, D.A., Klein, L.L., Marsh, K. Antimicrob. Agents Chemother. (2006) [Pubmed]
  3. Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine. Kempf, D.J., King, M.S., Bernstein, B., Cernohous, P., Bauer, E., Moseley, J., Gu, K., Hsu, A., Brun, S., Sun, E. J. Infect. Dis. (2004) [Pubmed]
  4. Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapy. Kempf, D.J., Isaacson, J.D., King, M.S., Brun, S.C., Sylte, J., Richards, B., Bernstein, B., Rode, R., Sun, E. Antivir. Ther. (Lond.) (2002) [Pubmed]
  5. Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. Kempf, D.J., Isaacson, J.D., King, M.S., Brun, S.C., Xu, Y., Real, K., Bernstein, B.M., Japour, A.J., Sun, E., Rode, R.A. J. Virol. (2001) [Pubmed]
WikiGenes - Universities